Co-authors

Researcher identifiers

Export Publications

Export the displayed publications:
Number of documents

6

Olivier Colliot - Research Director at CNRS - ARAMIS Lab (CNRS/INRIA/Inserm/UPMC)


Research Director at CNRS

 

Head of the ARAMIS Lab, a joint team between CNRSInriaInserm and University Pierre and Marie Curie at the Brain and Spine Institute (ICM), in co-direction with Didier Dormont.

 


"Harald Hampel"    "Stéphane Lehéricy"   

Journal articles6 documents

  • Michel Thiebaut de Schotten, Hovagim Bakardjian, Habib Benali, Hugo Bertin, Joel Bonheur, et al.. Differential default mode network trajectories in asymptomatic individuals at risk for Alzheimer's disease. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, Elsevier, 2019, 15 (7), pp.940-950. ⟨10.1016/j.jalz.2019.03.006⟩. ⟨hal-02368904⟩
  • Harald Hampel, Nicola Toschi, Claudio Babiloni, Filippo Baldacci, Keith Black, et al.. Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology. Journal of Alzheimer's Disease, IOS Press, 2018, 64 (s1), pp.S47 - S105. ⟨10.3233/jad-179932⟩. ⟨hal-01910402⟩
  • Enrica Cavedo, Michel J Grothe, Olivier Colliot, Simone Lista, Marie Chupin, et al.. Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer's disease. Scientific Reports, Nature Publishing Group, 2017, 7 (1), pp.11706. ⟨10.1038/s41598-017-09780-3⟩. ⟨hal-01589622⟩
  • Enrica Cavedo, Bruno Dubois, Olivier Colliot, Simone Lista, Bernard Croisile, et al.. Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer’s Disease. Journal of Clinical Psychiatry, Physicians Postgraduate Press, 2016, ⟨10.4088/JCP.15m10413 ⟩. ⟨hal-01388951⟩
  • Bruno Dubois, Marie Chupin, Harald Hampel, Simone Lista, Enrica Cavedo, et al.. Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease. Alzheimer's and Dementia, Elsevier, 2015, 11 (9), pp.1041-1049. ⟨10.1016/j.jalz.2014.10.003⟩. ⟨hal-01249861⟩
  • Harald Hampel, Simone Lista, Stefan J Teipel, Francesco Garaci, Robert Nisticò, et al.. Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020. Biochemical Pharmacology, Elsevier, 2014, pp.426-49. ⟨hal-01098832⟩